ArticleVirology journal2026

HBsAg glycan isomer predicts on-treatment HBsAg decline in low-HBsAg chronic hepatitis B on nucleos(t)ide therapy.

Daisuke Yokoyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.